Celgene's most recent trend suggests a bearish bias. One trading opportunity on Celgene is a Bear Call Spread using a strike $114.00 short call and a strike $119.00 long call offers a potential 41.24% return on risk over the next 23 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $114.00 by expiration. The full premium credit of $1.46 would be kept by the premium seller. The risk of $3.54 would be incurred if the stock rose above the $119.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Celgene is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Celgene is bearish.
The RSI indicator is at 21.98 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary
Tue, 24 Jan 2017 20:03:30 GMT
Celgene Is Advancing Research in Myeloid Disease Segment
Tue, 24 Jan 2017 15:37:34 GMT
Celgene Targets Anemia Opportunity with Luspatercept
Tue, 24 Jan 2017 14:06:35 GMT
3 Biotech Stocks to Buy and Hold Stress-Free
Tue, 24 Jan 2017 13:13:00 GMT
Celgene to Target Unmet Demand in Myeloid Disease Segment
Tue, 24 Jan 2017 12:37:45 GMT
Also on Market Tamer…
Follow Us on Facebook